Andon Health Co., Ltd. (SHE:002432)
China · Delayed Price · Currency is CNY 41.23
-0.68 (-1.62%)
At close: Feb 13, 2026
Andon Health Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 1,889 | 1,669 | 1,252 | 16,030 | 908.64 | 242.33 |
Depreciation & Amortization | 44.16 | 44.16 | 105.17 | 106.05 | 89.36 | 62.78 |
Other Amortization | 23.94 | 23.94 | 2.45 | 36.95 | 7.61 | 29.82 |
Loss (Gain) From Sale of Assets | -0.67 | -0.67 | 0.5 | 6.43 | -0.01 | 0.03 |
Asset Writedown & Restructuring Costs | 25.45 | 25.45 | 242.65 | 172.22 | 1.88 | 147.72 |
Loss (Gain) From Sale of Investments | -1,448 | -1,448 | -870.03 | 232.92 | -74.25 | 19.38 |
Provision & Write-off of Bad Debts | 2.63 | 2.63 | -2.67 | 12.59 | 23.43 | 9.58 |
Other Operating Activities | -726.34 | 223.23 | 208.5 | 620.88 | 46.51 | 30.55 |
Change in Accounts Receivable | 2.97 | 2.97 | 401.76 | 353.29 | -718.62 | -68.84 |
Change in Inventory | 197.13 | 197.13 | 400.22 | -220.92 | -332.14 | -87.1 |
Change in Accounts Payable | 89.38 | 89.38 | -279.88 | -196.62 | 361.91 | 81.42 |
Change in Other Net Operating Assets | 86.38 | 86.38 | 220.92 | 185.32 | 9.17 | 2.05 |
Operating Cash Flow | 257.6 | 986.75 | 1,770 | 18,222 | 293.11 | 461.62 |
Operating Cash Flow Growth | -63.86% | -44.26% | -90.29% | 6116.59% | -36.50% | - |
Capital Expenditures | -268.94 | -73.92 | -212.65 | -211.9 | -70.45 | -53.77 |
Sale of Property, Plant & Equipment | 1.57 | 0.86 | 0.58 | 0.46 | 0.1 | 0.01 |
Cash Acquisitions | -1.87 | - | - | - | - | - |
Divestitures | - | - | -7.2 | - | - | -18.82 |
Investment in Securities | -1,639 | -1,104 | -4,214 | -12,798 | -345.66 | -357.53 |
Other Investing Activities | 1,016 | 595.47 | 247.35 | 66.11 | 58.78 | 321.71 |
Investing Cash Flow | -892.51 | -581.27 | -4,186 | -12,943 | -357.22 | -108.41 |
Short-Term Debt Issued | - | - | - | - | 237.12 | - |
Long-Term Debt Issued | - | 3,603 | 1,529 | 256.75 | - | 172.68 |
Total Debt Issued | 7,821 | 3,603 | 1,529 | 256.75 | 237.12 | 172.68 |
Short-Term Debt Repaid | - | - | - | - | -253.62 | - |
Long-Term Debt Repaid | - | -1,864 | -290.02 | -349.68 | -24.3 | -9.49 |
Total Debt Repaid | -5,915 | -1,864 | -290.02 | -349.68 | -277.92 | -9.49 |
Net Debt Issued (Repaid) | 1,906 | 1,739 | 1,239 | -92.93 | -40.8 | 163.19 |
Issuance of Common Stock | 394.89 | 394.89 | 24.44 | 139.14 | 342.64 | - |
Repurchase of Common Stock | -1,198 | -1,198 | -1,000 | - | -199.84 | - |
Common Dividends Paid | -218.11 | -190.66 | -1,187 | -322.03 | -36.68 | -6.67 |
Other Financing Activities | 560.82 | -649.18 | - | - | -0.33 | -0.82 |
Financing Cash Flow | 1,446 | 96.21 | -922.78 | -275.82 | 65 | 155.7 |
Foreign Exchange Rate Adjustments | 37.9 | 43.94 | 69.44 | 15.8 | -14.24 | -28.02 |
Net Cash Flow | 849.12 | 545.63 | -3,269 | 5,018 | -13.35 | 480.89 |
Free Cash Flow | -11.34 | 912.83 | 1,557 | 18,010 | 222.67 | 407.85 |
Free Cash Flow Growth | - | -41.39% | -91.35% | 7988.15% | -45.41% | - |
Free Cash Flow Margin | -0.72% | 35.22% | 48.20% | 68.44% | 9.29% | 20.31% |
Free Cash Flow Per Share | -0.03 | 2.07 | 3.44 | 38.53 | 0.49 | 0.94 |
Cash Income Tax Paid | 23.17 | 105.24 | 40.86 | 1,009 | -15.62 | -27.53 |
Levered Free Cash Flow | -278.99 | 772.76 | 1,144 | 11,554 | -4.26 | 272.04 |
Unlevered Free Cash Flow | -212.17 | 814.73 | 1,152 | 11,557 | 4.05 | 276.39 |
Change in Working Capital | 447.36 | 447.36 | 831.94 | 1,003 | -710.06 | -80.55 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.